TGFB1 and chronic kidney disease: Early intervention with RAS inhibition is able to attenuate cardiac fibrosis and antagonize activation of the fibrogenic TGF-β signaling pathway in UUO/CKD mice, and highlights the importance of early recognition and intervention for pre-clinical CRS.